Home 2023

Phase I clinical trials (Drug development)

6 Immuno-oncology Startups Attracting the Biggest VC Cash
Cancer

6 Immuno-oncology Startups Attracting the Biggest VC Cash

Kathy Vuksanaj -
0
Cellares and Lyell Evaluate CAR T-Cell Automated Manufacturing
Bioprocessing

Cellares and Lyell Evaluate CAR T-Cell Automated Manufacturing

John Sterling -
0
Shuttle Launch: Cellares’ Smart Factories Aim to Meet Cell Therapy Demand at Global Scale
Artificial Intelligence

Shuttle Launch: Cellares’ Smart Factories Aim to Meet Cell Therapy Demand at Global Scale

Jonathan D Grinstein, PhD -
0
Charles River Signs Two Gene Therapy Manufacturing Agreements
Bioprocessing

Charles River Signs Two Gene Therapy Manufacturing Agreements

John Sterling -
2
Bispecific Antibodies Expose Tumors to New Lines of Attack
Cancer

Bispecific Antibodies Expose Tumors to New Lines of Attack

Kathy Vuksanaj -
0
Molecular Scissors Are Making the Cut … in Clinical Trials
Genome Editing

Molecular Scissors Are Making the Cut … in Clinical Trials

Kathy Vuksanaj -
0
Astellas to Acquire Iveric Bio for $5.9B, Expanding Eye Disease Pipeline
Drug Discovery

Astellas to Acquire Iveric Bio for $5.9B, Expanding Eye Disease Pipeline

Alex Philippidis -
0
Generate:Biomedicines and MD Anderson Sign AI-Driven Protein Therapeutics for Cancer Deal
Artificial Intelligence

Generate:Biomedicines and MD Anderson Sign AI-Driven Protein Therapeutics for Cancer Deal

John Sterling -
0
AACR News: Evaxion’s DNA-Based Personalized Cancer Immunotherapy EVX-02 Meets Phase I/IIa Endpoints
Cancer

AACR News: Evaxion’s DNA-Based Personalized Cancer Immunotherapy EVX-02 Meets Phase I/IIa Endpoints

Jonathan D Grinstein, PhD -
0
Nasal COVID-19 Vaccine Shows Promise
Coronavirus

Nasal COVID-19 Vaccine Shows Promise

Julianna LeMieux, PhD -
24
123...38Page 1 of 38
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.